Data / Form D filings / Abogen, Inc.
Abogen, Inc.: Form D filing
Abogen, Inc., a biotechnology company in Portland, ME, filed a Form D with the SEC in 2017. The latest, on July 31, 2017, reports $25,000 sold of a $4 million offering to 1 investor.
Find out what Abogen, Inc. does, who founded it and who invested, beyond what the filing says. $10 of credit on sign-up, no card.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 477 CONGRESS STREET, SUITE 1010, Portland, ME, 04101
- Phone
- (207) 939-1665
- Industry
- Biotechnology
- Entity type
- Corporation
- Incorporated in
- Maine
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 1700326
The full lists. Form D filings in Maine: 101 rows, $5.05, or the new rows each week for $19 a month. Form D filings in Biotechnology: 1,568 rows, $78.40, or the new rows each week for $19 a month. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (company, CIK, year incorporated, street, city, state and 5 more), which open on your screen as soon as the payment clears and come by email. For agents and scripts: every list with its row count and price is at https://specstream.ai/data/lists.json.
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Jul 31, 2017 | New notice | $4,000,000 | $25,000 | $3,975,000 | 1 | Jul 28, 2017 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Michael Steele | Executive Officer | |
| Fred Pancholy Heimann | Director | |
| Ken Pancholy Martin | Director | |
| Jacques Pancholy Essinger | Director | |
| Manasi Pancholy Jain | Executive Officer | |
| Stephen Andrews | Executive Officer, Director, Promoter | |
| Youssef Biahillah | Executive Officer, Director, Promoter |
Every Form D from the week of Jul 31, 2017 · All recent filings in Maine · All recent Biotechnology filings
Read from SEC EDGAR. Amount sold is what Abogen, Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.
$10 of credit on sign-up, no card.